GDx VCC Nerve Fiber Analyzer
|
 |
The GDx VCC is the only glaucoma detection technology available that directly and objectively evaluates the nerve fiber layer of the eye.
The test is fast and comfortable for your patient.
|
|
While the three most common tests for glaucoma (the pressure check or puff test, visual field analysis, and optic nerve evaluation) are useful, they often do not detect glaucoma early enough.
The GDx VCC is the only glaucoma detection technology available that directly and objectively evaluates the nerve fiber layer of the eye. This test is comfortable, does not require drops or pupil dilation and provides results for both eyes within three minutes.
Breakthrough Technology
Now . . . early, accurate detection of RNFL damage in just 3 minutes with breakthrough Scanning Laser Ophthalmoscope technology that measures the extent of glaucoma damage where it occurs, at the retinal nerve fiber layer (RNFL).
Early diagnosis
• Retinal nerve fiber layer damage is present up to 6 years before visual field damage
True diagnosis
• Measurements are compared to a normative database to provide quick, easy and objective analysis
• Test parameters do not rely on questionable risk factors for glaucoma
• Nerve fiber analysis with polarimetry shows early damage caused by glaucoma
• Optic nerve head analysis can’t always differentiate anatomical cupping from cupping resulting from glaucoma
Fast diagnosis
• Less than 1 second to image
• exams in just minutes
• No dilation is required
Continual diagnosis and follow-up
• Typical image reproducibility of better than 15µm allows precise, accurate follow-up of change over time
• Serial analysis printout clearly shows specific areas of disease progression
|
Call for more information
|
(877) 931-2020
|
|
|
Ocular Blood Flow Analyzer
|
The Ocular Blood Flow Analyzer is a new tool to assist in the early diagnosis, understanding, and management of glaucoma. The BFA provides a fast, clinically proven measurement that improves detection of glaucoma suspects.
|
|
|
The Ocular Bloow Flow analyzer (BFA) assists in the management of glaucoma, and detection of other circulatory abnormalities involving diabetes, retinal and carotid disorders.
Clinical benefits of the BFA
• Identify low and normal-tension glaucoma suspects who tend to have significantly lower ocular blood flow (OBF) than normal. Low OBF's may put any part of the eye at risk.
Glaucoma is just one disease where abnormal OBF is likely to be a major risk factor.
• Identify vascular disorders in patients with greater asymmetry of OBF than 4 microliters per second with similar IOP's, ie. Internal carotid stenosis.
• Monitor ocular and systemic drugs that have the potential to modify OBF. This is particularly true of beta and calcium level blockers.
The Ocular Blood Flow Analyzer (BFA) is clinically proven test that increases early diagnosis of low and normal-tension glaucoma.
The BFA is now recognized as an important diagnostic measurement for your patient. The BFA records pulsatile ocular blood flow data, providing significant new information about the vascular network in the eye.
Studies have indicated that blood flow is significantly compromised in many eyes with normal-tension glaucoma, with and without field loss. The BFA improves your ability to monitor and manage your patients.
In one automatic 10 second measurement, information is captured and displayed on the screen. Data is printed on a concise patient record.
Numeric and graphic data in one test:
• IOP
• Pulse amplitude
• Systolic and diastolic cycles
• Ocular Blood Flow (microliters/sec)
The BFA's pneumotonometer has been shown to have greater accuracy in IOP measurement than traditional Goldmannn. Because the pneumotono-meter has a smaller applanation probe, the IOP findings are less influenced by variations in corneal thickness.
|
Call for more information
|
(877) 931-2020
|
|
